Endocrine factors associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome: Do androgens play a role?

References

• Targher G. Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens. Diabet Med 2007;24:1–6.
   PubMed Web of Science ®Google Scholar
• Ahmed MH, Osman MM. Non-alcoholic fatty liver disease and diabetes: a 21st century epidemic. Br J Hosp Med (Lond) 2006;67:267.
   PubMed Web of Science ®Google Scholar
• Lee R. Nonalcoholic steatohepatitis: a study of 49 patients. Hum Pathol 1989;20:594–598.
   PubMed Web of Science ®Google Scholar
• Clark J. The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol 2006;40(Suppl 1):S5–S10.
   PubMed Web of Science ®Google Scholar
• Wieckowska A, Feldstein A. Diagnosis of nonalcoholic fatty liver disease: invasive vs noninvasive. Semin Liver Dis 2008;28:386–395.
   PubMed Web of Science ®Google Scholar
• Hjelkrem M, Torres D, Harrison S. Nonalcoholic fatty liver disease. Minerva Med 2008;99:583–593.
   PubMedGoogle Scholar
• Torres D, Harrison S. Diagnosis and therapy of nonalcoholic steatohepatitis. Gastroenterology 2008;134:1682–1698.
   PubMed Web of Science ®Google Scholar
• Ludwig J, Viggiano T, McGill D, Oh B. Mayo Clinic experience with a hirther-to unnamed disease. Mayo Clin Proc 1980;55:434–438.
   PubMed Web of Science ®Google Scholar
• Goessling W, Massaro J, Vasan R, D'Agostino R, Ellison R, Fox C. Aminotransferase levesl and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease. Gastoenterology 2008;135:1935–1944.
   PubMed Web of Science ®Google Scholar
• Chang Y, Ryu S, Sung E, Jang Y. Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease. Clin Chem 2007;53:686–692.
   PubMed Web of Science ®Google Scholar
• Angulo P, Lindor KD. Non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2002;17(Suppl):S186–S190.
   PubMed Web of Science ®Google Scholar
• Utzschneider K, Kahn S. Review: the role of insulin resistance in nonalcoholic fatty liver disease. J Clin Endocrinol Metab 2006;91:4753–4761.
   PubMed Web of Science ®Google Scholar
• Kantartzis K, Machicao F, Machann J, Schick F, Fritsche A, Haring HU, Stefan N. The DGAT2 gene is a candidate for the dissociation between fatty liver and insulin resistance in humans. Clin Sci (Lond) 2009;116:537.
   Web of Science ®Google Scholar
• Stefan N, Hennige A, Staiger H, Machann J, Schick F, Krober S, Machicao F, Fritsche A, Haring HU. Alpha 2-Heresmans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 2006;29:853–857.
   PubMed Web of Science ®Google Scholar
• Bellentani S, Bedogni G, Tiribelli C. Liver and heart: a new link? J Hepatol 2008;49:300–302.
   PubMed Web of Science ®Google Scholar
• Dixon J, Bhathal PS, O'Brien P. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001;121:91–100.
   PubMed Web of Science ®Google Scholar
• Legro RS, Castracane VD, Kauffman RP. Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls. Obstet Gynecol Surv 2004;59:141–154.
   PubMed Web of Science ®Google Scholar
• Setji TL, Holland ND, Sanders LL, Pereira KC, Diehl AM, Brown AJ. Nonalcoholic steatohepatitis and nonalcoholic fatty liver disease in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 2006;91:1741–1747.
   PubMed Web of Science ®Google Scholar
• Gambarin-Gelwan M, Kinkhabwala SV, Schiano TD, Bodian C, Yeh HC, Futterweit W. Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome. Clin Gastroenterol Hepatol 2007;5:496–501.
   PubMed Web of Science ®Google Scholar
• Cerda C, Perez-Ayuso RM, Riquelme A, Soza A, Villaseca P, Sir-Petermann T, Espinoza M, Pizarro M, Solis N, Miquel JF, et al Nonalcoholic fatty liver disease in women with polycystic ovary syndrome. J Hepatol 2007;47:412–417.
   PubMed Web of Science ®Google Scholar
• Asagami T, Holmes TH, Reaven G. Differential effects of insulin sensitivity on androgens in obese women with polycystic ovary syndrome or normal ovulation. Metabolism 2008;57:1355–1360.
   PubMed Web of Science ®Google Scholar
• Zawadzki J, Dunaif A. Diagnostic criteria for PCOS: towards a rational approach. In: Dunaif A, Givens J, Haseltine F, Merriam G, editors. Polycystic ovary syndrome. Boston: Blackwell; 1992. pp 377–384.
   Google Scholar
• Hatch R, Rosenfield RL, Kim MH, Tredway D. Hirsutism: implications, etiology, and management. Am J Obstet Gynecol 1981;140:815–830.
   PubMed Web of Science ®Google Scholar
• Powell E, Cooksley W, Hanson R, Searle J, Halliday J, Powell L. The natural history of steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatol 1990;11:74–80.
   PubMed Web of Science ®Google Scholar
• Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Jarvinen H, van Haeften T, et al Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 2000;23:295–301.
   PubMed Web of Science ®Google Scholar
• Stumvoll M, van Haeften T, Fritsche A, Gerich J. Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times. Diabetes Care 2001;24:796–797.
   PubMed Web of Science ®Google Scholar
• Matsuda M, DeFronzo R. Insulin sensitivity indicies obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999;22:1462–1470.
   PubMed Web of Science ®Google Scholar
• Rosner W, Auchus R, Sluss PM, Raff H. Position statement: utility, limitations, and pitfalls in measuring testosterone: an endocrine society position statement. J Clin Endocrinol Metab 2007;92:405–413.
   PubMed Web of Science ®Google Scholar
• Ruhl C, Everhart J. Joint effects of body wieght and alcohol on elevated serum alanine aminotransferase in the United States population. Clin Gastroenterol Hepatol 2005;3:1260–1268.
   PubMed Web of Science ®Google Scholar
• Jou J, Choi S, Diehl A. Mechanisms of disease progression in nonalcoholic fatty liver disease. Semin Liver Dis 2008;28:370–379.
   PubMed Web of Science ®Google Scholar
• Bellentani S, Saccoccio G, Masutti F, Corce L, Brandi G, Sasso F. Prevalence of and risk factors for hepatic steatosis in northern Italy. Ann Intern Med 2000;132:112–117.
   PubMed Web of Science ®Google Scholar
• NCEP Expert Panel. Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) Final Report. Circulation 2002;106:3143–3421.
   PubMed Web of Science ®Google Scholar
• Hanak V, Munoz J, Teague J, Stanley A, Bittner V. Accuracy of the tryglyceride to hig-density lipoprotein cholesterol ratio for prediction of the low-density lipoprotein phenotype B. Am J Cardiol 2004;94:219–222.
   PubMed Web of Science ®Google Scholar
• Dahan MH, Goldstein J. Serum sex hormone-binding globulin levels show too much variability to be used effectively as a screening marker for insulin resistance in women with polycystic ovary syndrome. Fertil Steril 2006;86:934–941.
   PubMed Web of Science ®Google Scholar
• Jayagopal V, Kilpatrick ES, Jennings PE, Hepburn DA, Atkin SL. The biological variation of testosterone and sex hormone-binding globulin (SHBG) in polycystic ovarian syndrome: implications for SHBG as a surrogate marker of insulin resistance. J Clin Endocrinol Metab 2003;88:1528–1533.
   PubMed Web of Science ®Google Scholar
• Kauffman RP, Baker TE, Baker VM, DiMarino P, Castracane VD. Endocrine and metabolic differences among phenotypic expressions of polycystic ovary syndrome according to the 2003 Rotterdam consensus criteria. Am J Obstet Gynecol 2008;198:670–677.
   PubMed Web of Science ®Google Scholar
• Stefan N, Kantartzis K, Haring H. Causes and metabolic consequences of fatty liver. Endocrinol Rev 2008;29:939–960.
   PubMed Web of Science ®Google Scholar
• Roldan-Valadez E, Favila R, Martinez-Lopez M, Uribe M, Mendez-Sanchez N. Imaging techniques for assessing hepatic fat content in nonalcoholic fatty liver disease. Ann Hepatol 2008;7:212–220.
   PubMed Web of Science ®Google Scholar
• Luque-Ramirez M, Mendieta-Azcona C, Alvarez-Blasco F, Escobar-Morreale HF. Androgen excess is associated with the increased carotid intima-media thickness observed in young women with polycystic ovary syndrome. Hum Reprod 2007;22:3197–3203.
   PubMed Web of Science ®Google Scholar
• Kantartzis K, Thamer C, Peter A, Machann J, Schick F, Schraml C, Konigsrainer A, Kinogsrainer I, Krober S, Niess A, et al High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease. Gut 2008. Published online 11 December 2008 ahead of print.
   PubMed Web of Science ®Google Scholar
• Preiss D, Sattar N, Harborne L, Norman J, Fleming R. The effects of 8 months of metformin on circulating GGT and ALT levels in obese women with polycystic ovarian syndrome. Int J Clin Pract 2008;62:1337–1343.
   PubMed Web of Science ®Google Scholar
• Ahmed MH, Byrne CD. Current treatment of non-alcoholic fatty liver disease. Diabetes Obes Metab 2009;11:188–195.
   PubMed Web of Science ®Google Scholar
• Belfort R, Harrison S, Brown K, Darland C, FInch J, Hardies J, et al A placebo-controlled trial of pioglitazone in subjects with non-alcoholic steatohepatitis. N Engl J Med 2006;355:2297–2307.
   PubMed Web of Science ®Google Scholar